Hindustan Bio Sciences Limited (BOM:532041)

India · Delayed Price · Currency is INR

7.97

-0.41 (-4.89%)

At close: Mar 9, 2026

-0.13% (1Y)

Market Cap	77.70M -8.6%
Revenue (ttm)	11.35M +40.1%
Net Income	1.48M +326.3%
EPS	0.16 +376.1%
Shares Out	10.25M
PE Ratio	48.69
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	262
Average Volume	10,465
Open	8.36
Previous Close	8.38
Day's Range	7.97 - 8.36
52-Week Range	5.00 - 10.32
Beta	-1.06
RSI	53.30
Earnings Date	May 29, 2026

About Hindustan Bio Sciences

Hindustan Bio Sciences Limited engages in the manufacturing and sale of pharmaceutical products in India. The company offers tablets, capsules, drops, externels, and syrups. It is also involved in marketing a nephrology product, recombinant human Erythropotien; and trading of drugs and medicines. In addition, the company exports its products. Hindustan Bio Sciences Limited was incorporated in 1991 and is based in Hyderabad, India. [Read more]

Industry Biological Products, Except Diagnostic Substances

Founded 1991

Employees 2

Stock Exchange Bombay Stock Exchange

Ticker Symbol 532041

Full Company Profile

Financial Performance

In fiscal year 2025, Hindustan Bio Sciences's revenue was 8.13 million, a decrease of -22.75% compared to the previous year's 10.53 million. Earnings were 1.01 million, an increase of 74.83%.

Financial Statements